ANRIL is transcribed from the well‐known 9p21.3 cardiovascular disease locus, which has been strongly implicated in coronary artery disease (CAD) through genome‐wide association studies [49, 50, 51, 52]. This evidence concerns the gene CDKN2B-AS1 and coronary artery disorder.